The ANRP is focused on facilitating the most innovative brain imaging research, while leveraging the technical and clinical advantages of the Icahn School of Medicine at Mount Sinai (ISMMS).
The program’s scientific mission is to develop advanced imaging technologies and apply them to improve diagnosis, treatment and surgical planning for neurological diseases, ultimately leading to a deeper understanding of the brain in the diseased as well as normal state. ANRP-affiliated laboratories span multiple departments at the ISMMS, including Neuroscience, Neurosurgery, Psychiatry, Radiology, Neurology and Genetics and Genomic Sciences. To support ANRP’s mission, Dr. Balchandani and her team guide the development of new acquisition methods, hardware, and analysis tools to provide advanced multi-modal imaging of the brain, including ultrahigh field MRI. She is also working towards ensuring that infrastructure for image acquisition and pre-processing is robust and seamless. The program will provide the support required to enable successful execution of pilot and funded studies and to help design new studies which may benefit from the suite of advanced brain imaging methods available at ISMMS.
We envision a growing number of ANRP-affiliated laboratories, spanning multiple departments in the Icahn School of Medicine at Mount Sinai, with shared interests that cross both departmental and institutional lines. The availability of established and expertly supported modalities for high-resolution brain imaging across research areas of interest will provide reliable, reproducible information about brain morphology, function, and microstructure, as well as information about resting-based and task-based functional connectivity in healthy brains and brains affected by disease.
Advanced Neuroimaging Lab:
Subtle changes in an individual’s heartbeat, which can be measured on an Apple Watch, are able to signal the onset of COVID-19 up to seven days before individuals are diagnosed with the infection. That preliminary observation was made by researchers at the Icahn...
Mount Sinai Hospital opens one of the first centers to study and treat people with what being called “Post-acute COVID Syndrome.”
Please click on the image to watch the 60 Minutes segment. New York, NY (November 22, 2020) — COVID-19 was initially thought to be a disease that was serious for the eldery and people with preexisting conditions. A potentially tough, but temporary respiratory illness...
Nanobiologic immunotherapy uses tiny, bioengineered material to harness immune systemNew York, NY (October 29, 2020) — A groundbreaking new type of cancer immunotherapy developed at the Icahn School of Medicine at Mount Sinai trains the innate immune system to help it...
Artificial intelligence–enabled rapid diagnosis of patients with COVID-19
Xueyan Mei, Hao-Chih Lee, […] Yang Yang
Nat Med (2020).
Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging
Max L. Senders, Anu E. Meerwaldt, ... Willem J. M. Mulder
Nat. Nanotechnol. 15, 398–405 (2020).